ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
TransMedics Group Inc

TransMedics Group Inc (TMDX)

65.29
-2.15
(-3.19%)
Cerrado 06 Marzo 3:00PM
64.98
-0.31
(-0.47%)
Fuera de horario: 6:59PM

Calls

StrikeCompraVentaUltimo PrecioP. MedioVariaciónVariación %VolumeInt AbiertoÚltimo Operado
30.0033.3037.6047.3035.450.000.00 %01-
35.0028.3032.6037.5230.450.000.00 %05-
40.0024.2026.9030.2025.550.000.00 %02-
45.000.000.000.000.000.000.00 %00-
50.0014.9017.2015.4416.05-3.36-17.87 %11806/3/2025
55.0010.2012.9019.0011.550.000.00 %022-
60.007.508.609.288.050.000.00 %082-
65.003.705.204.804.45-1.04-17.81 %11433206/3/2025
70.000.000.000.000.000.000.00 %00-
75.000.000.000.000.000.000.00 %00-
80.000.650.850.650.75-0.44-40.37 %10188706/3/2025
85.000.300.450.400.375-0.15-27.27 %6295306/3/2025
90.000.000.000.000.000.000.00 %00-
95.000.100.200.150.15-0.06-28.57 %965206/3/2025
100.000.100.300.150.20-0.05-25.00 %1855306/3/2025
105.000.000.000.000.000.000.00 %00-

Su centro para precios en tiempo real, ideas y debates en vivo

Puts

StrikeCompraVentaUltimo PrecioP. MedioVariaciónVariación %VolumeInt AbiertoÚltimo Operado
30.000.000.000.000.000.000.00 %00-
35.000.000.000.000.000.000.00 %00-
40.000.000.000.000.000.000.00 %00-
45.000.100.350.200.2250.0317.65 %511406/3/2025
50.000.000.000.000.000.000.00 %00-
55.000.000.000.000.000.000.00 %00-
60.000.000.000.000.000.000.00 %00-
65.000.000.000.000.000.000.00 %00-
70.007.007.408.207.201.7026.15 %4155206/3/2025
75.009.9011.8010.1010.850.000.00 %0416-
80.000.000.000.000.000.000.00 %00-
85.000.000.000.000.000.000.00 %00-
90.0023.4026.1018.0024.750.000.00 %027-
95.000.000.000.000.000.000.00 %00-
100.000.000.000.000.000.000.00 %00-
105.000.000.000.000.000.000.00 %00-

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
PSTVPlus Therapeutics Inc
US$ 1.46
(317.14%)
359.59M
AGMHAGM Group Holdings Inc
US$ 0.213
(108.21%)
694.71M
LZMHLZ Technology Holdings Ltd
US$ 9.79
(33.56%)
590.5k
TNXPTonix Pharmaceuticals Holding Corporation
US$ 14.62
(33.39%)
16.07M
GVVisionary Holdings Inc
US$ 4.89
(32.34%)
135.24M
BLNEEastside Distilling Inc
US$ 0.7846
(-89.40%)
12.25k
ACONAclarion Inc
US$ 1.5501
(-77.86%)
51.53M
ELABPMGC Holdings Inc
US$ 0.7132
(-42.02%)
1.51M
SNBRSleep Number Corporation
US$ 7.49
(-41.89%)
4.56M
CCLDCareCloud Inc
US$ 2.0904
(-33.00%)
1.23M
AGMHAGM Group Holdings Inc
US$ 0.213
(108.21%)
690.72M
PSTVPlus Therapeutics Inc
US$ 1.46
(317.14%)
357.55M
NVDANVIDIA Corporation
US$ 110.57
(-5.74%)
314.56M
GVVisionary Holdings Inc
US$ 4.89
(32.34%)
134.05M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10.75
(-11.38%)
131.89M

TMDX Discussion

Ver más
Monksdream Monksdream 10 meses hace
TMDX new 52+ week high
👍️0
Monksdream Monksdream 1 año hace
TMDX 10Q
👍️0
make it happen make it happen 1 año hace
Should touch $50 net lose widens, and has a 40% day. The structure shows over 100% ownership which technically should be illegal. How can there be over 100%? Imho mean institutions and whomever will be selling for a 40%ish profit overnight.
👍️0
crudeoil24 crudeoil24 4 años hace
TransMedics Late Tuesday Announced FDA Advisory Committee Panel Voted 12 To 5 That Benefits Of OCS Heart System Outweigh Risks
6:58 am ET April 7, 2021 (Benzinga) Print
TransMedics Group, Inc. ("TransMedics") (NASDAQ:TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that after the review of TransMedics' clinical evidence from the OCS Heart EXPAND trial, the associated Continued Access Protocol ("CAP") results, as well as the OCS Heart PROCEED II trial, the Circulatory Systems Device Advisory Panel convened by the U.S. Food and Drug Administration ("FDA") has issued a favorable vote in support of approval of the OCS Heart System to the FDA's Office of Health Technology 2 (Cardiovascular Devices). The panel voted 12 to 5, with 1 abstaining, that the benefits of the OCS Heart System outweigh its risks. The panel voted 10 to 6, with 2 abstaining, that there is reasonable assurance that the OCS Heart System is effective. The panel voted 9 to 7, with 2 abstaining, that there is reasonable assurance of the OCS Heart System's safety.

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
👍️0
crudeoil24 crudeoil24 4 años hace
Transmedics group, Inc. is a commercial-stage medical technology company. It is focused on developing organ transplant therapy for end-stage organ failure patients across multiple disease states. The Company has designed and developed organ care system (OCS) a portable organ perfusion, optimization and monitoring system that utilizes customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It has developed three OCS products, one for each of lung, heart and liver transplantations. Its OCS clinical programs include OCS Lung INSPIRE Trial, OCS Lung Expand Trial, OCs Heart EXPAND and PROCEED II Trials. Its organ care system (OCS) technology platform to perfuse donor organs with warm, oxygenated, nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile. It is also focused on developing additional OCS products for kidney transplantation.
👍️0

Su Consulta Reciente

Delayed Upgrade Clock